Protecting a drug patent by selling it to a Native American tribe
nytimes.com
nytimes.com
>I don’t understand how this strategy would work.
>The PTAB decisions about state colleges/universities are based on Eleventh Amendment immunity. On those cases, the IPR statute is trumped and cannot impede on the states’ sovereign immunity under the 11th Amendment.
>But Native American tribes do not enjoy 11th Amendment immunity; their immunity is a function of federal common law and Congress has near plenary statutory authority over the tribes. Congressional statutes can abrogate or supersede tribal immunity, without constitutional issues.
>Tribal immunity is more about immunity from the states over Native American tribes, based on federal supremacy over Native American affairs.
>But AIA is federal. So the argument is simple; by enacting the AIA and subjecting issued patents to AIA reviews, and not making any exception for patents owned by Native American tribes, it abrogated any sovereign immunity that may have applied.
>The patents obviously weren’t invented or originally prosecuted by the tribe; given the fact that the immunity is federal common law and policy-based (and not 11th Amendment-based), I can see that policy-based arguments about how manipulative this is, will be very receptive.
[0]https://patentlyo.com/patent/2017/09/allergan-creating-sover...
http://www.ipwatchdog.com/2017/03/16/ufrf-eleventh-amendment...
https://patentlyo.com/patent/2017/02/sovereign-university-ch...
And here's a later case involving the University of Maryland Baltimore where the reasoning was reaffirmed:
https://www.lexology.com/library/detail.aspx?g=e8a324fd-4be6...
I post this here as a response to 'rayiner' not because he can't find these links on his own, but because I'd be interested in his opinion one of the suggestions in that last Lexology link:
Third, public universities and hospital systems may see their research sponsors begin to stop demanding full ownership of patents resulting from sponsored research and/or clinical studies, in favor of a more natural joint ownership structure. Presumably, since all owners of a patent are necessary parties to an IPR (and district court litigation), even a private, for-profit entity that is a joint owner of a patent with a public university or hospital may be able to benefit from assertions of sovereign immunity in IPRs.
Does this multiple ownership theory of immunity make sense to you? Instead of transferring the entire patent to a sovereign Indian nation, would it be possible for them to make gift of some tiny percentage of ownership of the patent, and still gain all the benefits of sovereign immunity?
I have to say, from the outside the whole thing seems like a farce. Regardless of the form the review takes, Covidien's argument that a patent review is directed against the patent, rather than the owner, sure makes intuitive sense. It makes some sense that a sovereign state would be immune from charges of infringement, but seems absurd to me that the US government would no longer be allowed to review the claims of a patent because the ownership changed.
At this point, shouldn't we just ignore patents?
Drugs companies in the US are so completely protected from any meaningful international competition. And now even inside the US they are working on ways to take this further.
Your healthcare cost so much because of nonsense like this! Its the people who are getting Screwed again.
A court hack, not a guarantee to keep the patent.
Michael Carrier (in the article) notes the tribe "played no part" in the drug's development.
So the question that occurs to me is what about the tax arrangements made by tech companies to "sell" patents to foreign entities and then lease back the rights in what is transfer pricing [2] by any other name?
Those countries and entities played no part in that development either.
Not that I'm defending patents in general or in this case. I just wonder if people view the situations similarly.
One claim by the company is clearly absurd, calling the patent review board "double jeopardy". It's no mor doubl jeopardy than hearing a case in Federal district and appellate courts is (yes, yes, I know appellate courts don't try facts). The review process is meant to streamline th process and is simply the first step in a judicial review process.
Really the big problem is that double Jeopardy is a criminal law concept, so Saunders' argument makes no sense.
Civil litigation like patent litigation is subject only to the restrictions of res judicata. If 300 million people want to challenge a patent 300 million times, they can (assuming standing, jurisdiction, etc...).
But also, we've been reexamining patents forever, which is basically a slower IPR with standard and process tilted in Patent Owner's favor. That could also be done separate from, concurrent with or in addition to civil litigation.
I thought the Federal Circuit did a pretty good job on this issue, but then again, their record in front of SCOTUS recently is just awful.
By "doing nothing" what they really meant was "by not doing all that much work".
Compared to people who, you know, actually do hard, serious work for (much less of) a living.
So, this is one of the small benefits they can enjoy as a result of not contesting the authority of the US government to occupy the USA.
And you are envious of the useful idiots instead of the corporation. That is thinking small...
By your flawed logic, someone who inherits a building also have put no monetary investment on what they are renting. You might as well also say that holocaust survivors won the lottery, by that logic.
Indian tribes, and every minority that managed to gain any stop-gap benefit, have to invest a lot of effort and time in maintaining their immunity/rights/etc. And this obviously greedy move, make that work harder in the medium/long term for them and every other tribe. So in a way they are putting in a investment.
But legislative and tax loopholes and corporate shelter nations/jurisdictions are.
Writing it off as a tax loss only covers a small percentage of the loss and assumes you have another gain to offset.
I guess the next step for patent holders if this doesn't pan out is paying small countries to hold patents with their actual sovereign immunity instead of almost immunity.
On the other hand, maybe the patent itself can be sued a la civil forfeiture, which would make the standing of the patent holders irrelevant.
It's a gamble.